Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Neurology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Gefurulimab Improved Generalised Myasthenia Gravis Symptoms
August 2026
Gefurulimab rapidly improved generalised myasthenia gravis symptoms and was well tolerated over 26 weeks.
Read more
3 Aug 2026
Gefurulimab Improved Generalised Myasthenia Gravis Symptoms
Gefurulimab rapidly improved generalised myasthenia gravis symptoms and was well tolerated over 26 weeks.
3 Aug 2026
Salivary Cortisol Patterns May Predict Cognitive Decline
A large cohort study has found that diurnal salivary cortisol patterns were linked to cognitive decline in older adults.
1 Aug 2026
Migraine Improvement Reduces Disability and Work Impairment
A longitudinal study of 11,634 adults found that improvements in migraine over 1 year were associated with better quality of life, reduced disability, lower stigma, and improved workplace functioning.
31 Jul 2026
Infections Linked to Higher Psychiatric Risk Over Two Years
A study has found that hospitalisation for infections, especially encephalitis, is linked to higher psychiatric and neurologic disorder risk over two years.
30 Jul 2026
Living With a Spouse With Dementia May Raise Your Own Risk
Spouses of individuals with dementia had up to 74% greater dementia risk than matched controls, a nationwide study found.
29 Jul 2026
Too Much Sleep Linked to Higher Dementia Biomarker Levels
Sleeping more than 8.5 hours was linked to elevated p-tau181, a dementia biomarker, in a new Framingham Heart Study analysis.
27 Jul 2026
Wildfire Smoke Pollution Linked to Increased Migraines
New research from across a large cohort study in Canada has found that worsened migraine symptoms were associated with particle PM2.5, a component of wildfire smoke.
27 Jul 2026
Road Traffic Noise Linked to Higher Parkinson Disease Risk
A Danish cohort study of over 3 million people found road traffic noise was linked to a higher risk of Parkinson disease.
Loading posts...
1
2
3
…
68
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View